wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36104098-242A6E25-86F5-44A4-913A-0AAE0CBFC7FB
Q36104098-242A6E25-86F5-44A4-913A-0AAE0CBFC7FB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36104098-242A6E25-86F5-44A4-913A-0AAE0CBFC7FB
Ponatinib as first-line treatment for patients with chronic myeloid leukaemia in chronic phase: a phase 2 study.
P2860
Q36104098-242A6E25-86F5-44A4-913A-0AAE0CBFC7FB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36104098-242A6E25-86F5-44A4-913A-0AAE0CBFC7FB
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0baedd2c3de1a52be91b4e7c442f9fe276035175
P2860
Comparison of imatinib 400 mg and 800 mg daily in the front-line treatment of high-risk, Philadelphia-positive chronic myeloid leukemia: a European LeukemiaNet Study.